Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial

  1. Pothuri, B.
  2. Han, S.
  3. Chase, D.M.
  4. Heitz, F.
  5. Burger, R.A.
  6. Gaba, L.
  7. Van Le, L.
  8. Guerra, E.
  9. Bender, D.
  10. Korach, J.
  11. Cloven, N.
  12. Churruca, C.
  13. Follana, P.
  14. DiSilvestro, P.
  15. Baurain, J.-F.
  16. Jardon, K.
  17. Pisano, C.
  18. Peen, U.
  19. Mäenpää, J.
  20. Gupta, D.
  21. Bacqué, E.
  22. Li, Y.
  23. Compton, N.
  24. Antonova, J.
  25. Monk, B.J.
  26. González-Martín, A.
  27. Montrer des auteurs +
Revue:
Gynecologic Oncology

ISSN: 1095-6859,  0090-8258

Année de publication: 2024

Volumen: 184

Pages: 168-177

Type: Article

DOI: 10.1016/J.YGYNO.2024.01.021 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objetivos de desarrollo sostenible

La source de données: Scopus